UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors

    • Categories

    Archives

    Feb

    22

    Rare Disease Day 2024: The Moment is Now to Be Patient-First to Deliver for People Living with Rare Diseases

    Read More Share:linkedin| twitter| email| facebook

    Feb

    12

    Harmony in Health: Partnering for Enhanced Seizure Management and Understanding

    Read More Share:linkedin| twitter| email| facebook

    Jan

    11

    Our Wish in 2024: Renewed Hope for People Living with Chronic Inflammatory Diseases

    Read More Share:linkedin| twitter| email| facebook

    Dec

    01

    Media Statement on levetiracetam (KEPPRA® and KEPPRA XR®) and DRESS

    Read More Share:linkedin| twitter| email| facebook

    Oct

    18

    Evolving Expectations for Dermatological Conditions

    Read More Share:linkedin| twitter| email| facebook

    Oct

    17

    Steadfast Towards Our Ambition to Create a UCB Rare Disease Portfolio

    Read More Share:linkedin| twitter| email| facebook

    Sep

    11

    UCB PharmD Second-Year Fellows Share Reflections and Advice

    Read More Share:linkedin| twitter| email| facebook

    Aug

    03

    Employee Spotlight: David Hornbaker’s Heart for Helping Patients

    Read More Share:linkedin| twitter| email| facebook

    Aug

    01

    Evolving Expectations for Dermatological Conditions

    Read More Share:linkedin| twitter| email| facebook

    Jun

    27

    Fulfilling Our Ambition to Deliver an FDA-Approved Treatment for People Living with Generalized Myasthenia Gravis

    Read More Share:linkedin| twitter| email| facebook

    © 2009 - 2025 UCB, Inc. Atlanta. All rights reserved. 
    Last updated: August 2025